NS
CYTK icon

NBC Securities’s Cytokinetics CYTK Stock Holding History

NBC Securities’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2K Sell
231
-2,053
-90% -$130K ﹤0.01% 1797
2025
Q4 		$145K Buy
2,284
+1,903
+499% +$118K 0.01% 951
2025
Q3 		$20.9K Hold
381
– – ﹤0.01% 1723
2025
Q2 		$12K Hold
381
– – ﹤0.01% 1886
2025
Q1 		$15K Buy
+381
New +$17.5K ﹤0.01% 1594
2024
Q4 		– Sell
-381
Closed -$20K – 1442
2024
Q3 		$20K Hold
381
– – ﹤0.01% 1502
2024
Q2 		$20K Buy
381
+150
+65% +$9.05K ﹤0.01% 1449
2024
Q1 		$16K Hold
231
– – ﹤0.01% 1522
2023
Q4 		$19K Hold
231
– – ﹤0.01% 1497
2023
Q3 		$6K Buy
+231
New +$7.69K ﹤0.01% 1822

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return